SCHEMBL19949459

SCHEMBL19949459

CC(c1ccnc(C#N)c1N)N1CCOCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
CTSK P43235 5/20 0.35
ALDH1A1 P00352 8/20 0.35
KDM4E B2RXH2 5/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPK1 P28482 1/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
KCNA5 P22460 1/20 0.33
KCNH2 Q12809 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
CDC42BPB Q9Y5S2 1/20 0.33
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19949437 0.84 ALDH1A1 (0.38) GAACTSKALDH1A1KDM4EHPGD
SCHEMBL19949458 0.82 GAA (0.37) GAACTSKALDH1A1KDM4EHPGD
SCHEMBL19949449 0.75 ATR (0.45) ALDH1A1KDM4EHSD17B10KCNA5KCNH2
SCHEMBL19949436 0.71 ALDH1A1 (0.36) GAACTSKALDH1A1KDM4EHPGD
SCHEMBL16272261 0.71 KCNA5 (0.45) GAAALDH1A1KDM4EHSD17B10L3MBTL1
SCHEMBL4929760 0.70 TSHR (0.40) ALDH1A1HSD17B10LMNASMN1; SMN2KCNA5
SCHEMBL2711245 0.68 KDM4E (0.43) GAACTSKALDH1A1KDM4EHPGD
SCHEMBL6071989 0.67 HTT (0.44) GAACTSKALDH1A1KDM4EHPGD
SCHEMBL7745378 0.66 DPP4 (0.46) ALDH1A1LMNASMN1; SMN2KCNA5KCNH2
SCHEMBL8872297 0.65 CHRM2 (0.40) MEN1KMT2AROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10538491-B2 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators VANDERBILT UNIVERSITY (US) 2020-01-21 US disclosed
US-20180072674-A1 NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 VANDERBILT UNIVERSITY (US) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10538491-B2 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators GRM2, GRIA2, GRIN2A GAA 3835/4885CTSK 4694/4885ALDH1A1 3137/4885
US-20180072674-A1 NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 GRM2, GRM1, GRIN2A GAA 2565/4885CTSK 4001/4885ALDH1A1 4190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.